Abstract Cultured rat vascular smooth muscle cells (VSMCs) possess receptors for potent vasoconstrictor endothelin-1 (ET-1) as well as potent vasodilator natriuretic peptides (atrial, brain, and C-type natriuretic peptides [ANP, BNP, and CNP, respectively]). However, little is known about molecular interactions between endothelin receptors and natriuretic peptides in VSMCs. To elucidate whether natriuretic peptides regulate vascular endothelin receptors, we studied the effects of three natriuretic peptides on the capacity of 125 I-ET-1 binding and expression of endothelin type A (ET A ) and type B (ET B ) receptor mRNAs in cultured rat VSMCs. CNP (10" 6 mol/L) increased '"I-ET-1 binding capacity in a time-dependent manner (6 to 48 hours) and stimulated cyclic GMP (cGMP) generation in a dose-dependent manner (10~8 to 10" 6 mol/L). Pretreatment with CNP (1(T 8 to 10" 6 mol/L) and 8-bromo-cGMP (10" 5 to 10~3 mol/L) for 24 hours resulted in dose-dependent increases in 125 I-ET-1 binding in VSMCs. The three natriuretic peptides at the highest concentration (10~6 mol/L) increased '"I-ET-1 binding and stimulated E ndothelin is a potent vasoconstrictor peptide originally isolated from cultured vascular endothelial cells. 1 cDNA cloning subsequently has revealed three endothelin isopeptides (ET-1, ET-2, and ET-3).
I-ET-1 binding in VSMCs.
The three natriuretic peptides at the highest concentration (10~6 mol/L) increased '"I-ET-1 binding and stimulated E ndothelin is a potent vasoconstrictor peptide originally isolated from cultured vascular endothelial cells. 1 cDNA cloning subsequently has revealed three endothelin isopeptides (ET-1, ET-2, and ET-3). 2 At least two receptor subtypes for endothelin isopeptides have been known to date 3 ' 4 : an ET-1-selective subtype (ET A ) and a non-isopeptide-selective subtype (ET B ). We have recently shown that cultured rat vascular smooth muscle cells (VSMCs) acquired ET B receptors other than ET A receptors during phenotypic change, whereas the ET A receptor is predominant in intact media. 5 C-type natriuretic peptide (CNP), the third member of the natriuretic peptide family, has recently been identified from porcine brain. 6 The pharmacologic spectrum of CNP, such as natriuretic/diuretic and hypotensive effects, was much less potent than that of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), 6 suggesting the heterogeneity of natriuretic peptide family receptors. At least three receptors for natriuretic peptides have been cloned and sequenced: two guanylyl cyclase-linked receptors, termed ANP-A (GC-A) receptor and ANP-B (GC-B) receptor, and a guanylyl cyclase-free receptor, termed ANP-C (clearance) receptor. 79 It has been shown that CNP selectively activates ANP-B receptors, suggesting that CNP is From the Second Department of Internal Medicine, Tokyo (Japan) Medical and Dental University.
Correspondence 10 Although CNP has been suggested to act as a neuropeptide, it has been recently shown that cultured rat VSMCs possess ANP-B (GC-B) receptors through which CNP stimulates cyclic GMP (cGMP) production more potently than ANP. 11 However, little is known about molecular interactions between vasoconstrictor ET-1 and vasodilator natriuretic peptides in VSMCs. To elucidate the interaction of natriuretic peptides with endothelin receptors in VSMCs, we studied the effects of CNP on endothelin receptors in cultured rat VSMCs by 125 I-ET-1 binding study and Northern blot analysis using ET A and ET B receptor cDNA as probes.
Methods Compounds
Synthetic rat ANP(l-28) (rANP), rat BNP(l-32) (rBNP), CNP(l-22), and ET-1 were purchased from Peptide Institute Inc; 8-bromo-cGMP and 3-isobutyl-l-methylxanthine (IBMX) from Sigma Chemical Co; the cGMP-dependent protein kinase inhibitor 
Cell Culture
VSMCs were prepared from the thoracic aorta of 15-weekold male Wistar rats by the explant method and were cultured in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal calf serum at 37°C in a humidified atmosphere of 95% air-5% CO 2 as previously described. 3 Subcultured VSMCs (passages 10 through 15) were used in the experiments.
Binding Experiments
Confluent VSMCs (5X10 5 cells) were incubated in serumfree DMEM for 24 hours, after which cells were usually pretreated with three natriuretic peptides (rANP, rBNP, CNP) and 8-bromo-cGMP for 24 hours unless otherwise stated. Cells were incubated with 6 pmol/L 123 I-ET-1 at 37°C for 60 minutes in Hanks' balanced salt solution (HBSS) containing 0.1% bovine serum albumin in the same manner as reported. 13 After completion, cells were extensively washed and solubilized in 0.5N NaOH, and cell-bound radioactivity was determined. Specific binding was obtained by subtracting nonspecific binding in the presence of excess (4xlO~7 mol/L) unlabeled ET-1 from total binding.
Measurement of Inositol 1,4,5-Trisphosphate
Confluent VSMCs (5X1O 3 cells) pretreated with 10" 6 mol/L CNP and 10" 3 mol/L 8-bromo-cGMP for 24 hours were incubated at 37°C for 30 seconds in HBSS containing 10 mmol/L LiCl. Incubation was terminated by the addition of perchloric acid. Inositol 1,4,5-trisphosphate (IP 3 ) was measured by a radioreceptor assay kit (Du Pont) as reported.
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Measurement of Intracellular cGMP
Confluent VSMCs (5X10 3 cells per well) were incubated with or without 10~6 mol/L each of rANP, rBNP, and CNP at 37°C for 10 minutes in HBSS containing 0.5 mmol/L IBMX. Intracellular cGMP was determined by a radioimmunoassay kit (New England Nuclear) as reported.
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Northern Blot Analysis
Total RNAs from VSMCs were extracted by the acid guanidinium thiocyanate-phenol-chloroform method. 15 Northern blot analysis using cDNAs for rat ET A and ET B receptors as probes was performed as recently described. 5 Briefly, total RNAs (15 jig) from cultured VSMCs were separated by formaldehyde/1.1% agarose gel electrophoresis and transferred to a nylon membrane. cDNA probes for rat ET A and ET B receptors were labeled with [^JdCTP by the random-primed method and incubated at 42°C for 16 hours with the membranes in the presence of 50% formamide. The membranes were washed with 0.3 mol/L NaCl, 30 mmol/L sodium citrate, and 1% sodium dodecyl sulfate at 60°C and were autoradiographed on X-Omat AR film (Eastman Kodak Co) at -80°C for 3 days.
Statistical Analysis
Data are expressed as mean ± SEM. Statistical analysis was performed by unpaired Student's t test. A probability value less than .05 was considered statistically significant.
Results
As shown in (Fig 2A) . Approximately 28% and 47% of the increases in 125 I-ET-1 binding over control levels were induced with 10" 6 mol/L CNP and 10" 3 mol/L 8-bromocGMP, respectively. CNP also stimulated cGMP formation in VSMCs in a dose-dependent (10~8 to 10" 6 mol/L) manner (Fig 2B) . However, neither rANP nor rBNP (10~7 mol/L) affected 125 I-ET-1 binding (data not shown).
We also examined the effects of maximal concentrations (10~6 mol/L) of rANP, rBNP, and CNP on the binding capacities of 125 I-ET-1 and cGMP generation (Fig 3) . The three natriuretic peptides increased The effects of a guanylyl cyclase-linked natriuretic peptide receptor antagonist (HS-142-1) and a cGMPdependent protein kinase inhibitor (KT-5823) on CNPand 8-bromo-cGMP-induced upregulation of endothelin receptors were examined (Fig 5) . HS-142-1 (100 jig/mL) blocked CNP-induced upregulation of endothelin receptors (Fig 5A) . KT-5823 (10" 5 mol/L) completely blocked the upregulation of endothelin-receptors induced by 8-bromo-cGMP (10~3 mol/L) and CNP (10~6 mol/L), respectively (Fig 5B) . Neither HS-142-1 (100 /ig/mL) nor KT-5823 ( 19 and that the ET A receptor is heterologously upregulated by cyclic AMP 20 but downregulated by glucocorticoids. 21 In the present study we have demonstrated for the first time that CNP heterologously upregulates ET B receptors in cultured rat VSMCs.
It has been shown that cultured rat VSMCs possess ANP-B (GC-B) receptors, through which CNP stimulates cGMP production more potently than ANP. 11 In the present study we have confirmed that CNP dosedependently stimulates cGMP generation and further demonstrated that natriuretic peptides upregulate endothelin receptors with the same rank order of efficacy as for cGMP stimulation (CNP>rBNP>rANP), suggesting that CNP, among the three natriuretic peptides, Thus far, three distinct receptor subtypes for natriuretic peptides have been characterized: two guanylyl cyclase-containing receptors, termed ANP-A (GC-A) and ANP-B (GC-B), 78 and a guanylyl cyclase-free receptor, ANP-C (clearance). 9 CNP is a selective ligand for the ANP-B (GC-B) receptor, and ANP and BNP are selective ligands for the ANP-A (GC-A) receptor, both of which mediate biologic effects via cGMP-dependent mechanisms. 10 In contrast, the ANP-C receptor is nonselective for the three natriuretic peptides, which mediate metabolism and clearance of ligands. 910 Recently, a phenotypic change of natriuretic peptide receptors in vasculature has been reported 22 : GC-A is predominant in intact aortic media, whereas GC-B and clearance receptors predominate during in vitro culture conditions. It has recently been reported that HS-142-1, an antagonist for guanylyl cyclase-linked natriuretic peptide receptors, 12 competitively blocked CNP-induced cGMP production in cultured bovine VSMCs. 23 Our results have shown that CNP-induced upregulation of endothelin receptors is inhibited by HS-142-1 and the cGMP-dependent protein kinase inhibitor KT-5823. Taken together, these results 24 The present study has shown that upregulation of endothelin receptors by CNP and 8-bromocGMP is concomitantly associated with enhanced IP 3 formation stimulated by ET-1, suggesting that modulation of vascular endothelin receptors is functionally linked to signal transduction.
It remains unanswered which vascular endothelin receptor subtype is modulated by CNP and 8-bromocGMP. The present Northern blot analysis using rat ET A and ET B receptor cDNAs as probes has clearly demonstrated that CNP increases steady-state levels of ET B receptor mRNA but not of ET A receptor mRNA in cultured rat VSMCs. Although CNP was localized mainly in the nervous system, 6 it has recently been shown that CNP is also produced by the human monocytic cell line THP-1 25 and bovine vascular endothelial cells 26 under stimulated conditions. Furthermore, the phenotypic change of cultured VSMCs induces subtype switching of natriuretic peptide receptors from ANP-A (GC-A) receptors to ANP-B (GC-B) receptors. 22 Therefore, it is currently proposed that CNP locally produced by the vessel walls may participate in the antiproliferation of modulated VSMCs under pathological conditions. 27 We have recently demonstrated that cultured rat VSMCs acquire ET B receptors other than ET A receptors during phenotypic change, which potentiates mitogenic activity of ET-1 in VSMCs. 5 Taken together, these results make it possible to speculate that CNP locally secreted from activated macrophages and/or injured endothelium may also induce upregulation of ET B receptors via ANP-B (GC-B) receptors in modulated VSMCs, thereby leading to enhanced vasoconstrictive and mitogenic effects by ET-1 via ET B receptors in vascular lesions associated with atherosclerosis and hypertension. 
